ロード中...
Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes
Type 1 diabetes (T1D) is an autoimmune disease caused by the destruction of insulin-producing cells. Due to the ability of apoptotic cells clearance to induce tolerance, we previously generated liposomes rich in phophatidylserine (PS) –a feature of apoptotic cells– loaded with insulin peptides to mi...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis Group
2020-01-01
|
| シリーズ: | Artificial Cells, Nanomedicine, and Biotechnology |
| 主題: | |
| オンライン･アクセス: | https://www.tandfonline.com/doi/10.1080/21691401.2019.1699812 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|